Flerie AB Logo

Flerie AB

FLERIE | ST

Overview

Corporate Details

ISIN(s):
SE0022447348
LEI:
54930047C4A74IBXR037
Country:
Sweden
Address:
BERZELIUS VÄG 13, 171 65 Solna
Sector:
Health Care
Industry:
Pharmaceuticals

Description

Flerie AB is a pharmaceutical company focusing on immunological diseases with great medical needs for new treatment options. The portfolio of the company includes Immuno-Oncology, metabolic diseases, and biologics development and manufacturing organizations. Flerie was established in 2011 by Thomas Eldered, who co-founded and built one of the global top five drug manufacturers, Recipharm. Dr Carl-Johan Spak, now Senior Advisor, and Thomas laid the foundation for Flerie’s evergreen strategy and oversaw the early investments. Flerie sold Cormorant Pharmaceuticals to BMS in 2016 and Cobra Biologics to Cognate Bioservices in early 2020 – this enabled further investments. In 2018, Dr Ted Fjällman, then chief executive of one of the portfolio companies, joined as Venture Partner, later Partner and CEO of Flerie.

Social Media

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-08 15:30
Regulatory News Service
Bolagsverket har lämnat tillstånd att verkställa fusionsplanen mellan Flerie oc…
Swedish 44.9 KB
2025-08-08 15:30
Regulatory News Service
The Swedish Companies Registration Office has granted permission to implement t…
English 51.6 KB
2025-08-04 08:00
Regulatory News Service
SUBSTANSVÄRDE – 31 juli 2025
Swedish 43.5 KB
2025-08-04 08:00
Regulatory News Service
NET ASSET VALUE – 31 July 2025
English 43.0 KB
2025-07-31 09:00
Transaction in Own Shares
Styrelsen i Flerie beslutar om inlösen av samtliga aktier av serie C inom ramen…
Swedish 33.5 KB
2025-07-31 09:00
Declaration of Voting Results & Voting Rights Announcements
The Board of Directors of Flerie has resolved to redeem all Series C shares wit…
English 42.1 KB
2025-07-31 08:00
Earnings Release
Swedish 1.3 MB
2025-07-31 08:00
Interim Report
English 1.6 MB
2025-07-16 08:00
Takeover Announcement Report
Flerie AB:s dotterbolag Flerie Invest AB offentliggör slutligt utfall avseende …
Swedish 49.2 KB
2025-07-16 08:00
Takeover Announcement Report
Flerie AB’s subsidiary Flerie Invest AB announces final outcome of the mandator…
English 48.3 KB
2025-07-03 08:00
Regulatory News Service
SUBSTANSVÄRDE – 30 juni 2025
Swedish 43.5 KB
2025-07-03 08:00
Regulatory News Service
NET ASSET VALUE – 30 June 2025
English 43.1 KB
2025-07-01 08:00
Transaction in Own Shares
Styrelsen i Flerie beslutar om omvandling av stamaktier till aktier av serie C …
Swedish 42.3 KB
2025-07-01 08:00
Transaction in Own Shares
The Board of Directors of Flerie has resolved to convert ordinary shares into S…
English 42.3 KB
2025-06-16 10:00
Takeover Announcement Report
Flerie AB's subsidiary Flerie Invest AB publish the offer document for the mand…
English 47.2 KB

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
ABIVAX Logo ABIVAX France ABVX
Addex Therapeutics Ltd Logo Addex Therapeutics Ltd Switzerland ADXN
AegirBio AB Logo AegirBio AB Sweden AEGIR
AGRONOMICS LIMITED Logo AGRONOMICS LIMITED Isle of Man ANIC
AIREA PLC Logo AIREA PLC United Kingdom AIEA
Alkaloid AD Logo Alkaloid AD North Macedonia ALK
Alma Yesodot Ltd. Israel KVSR
Amphastar Pharmaceuticals Inc. Logo Amphastar Pharmaceuticals Inc. United States of America AMPH
Ananda Pharma Plc United Kingdom N/A
AnGes, Inc. Logo AnGes, Inc. Japan 4563